Annual report [Section 13 and 15(d), not S-K Item 405]

Stockholders??? Equity (Details)

v3.25.1
Stockholders’ Equity (Details) - USD ($)
 4 Months Ended 12 Months Ended
Oct. 24, 2024
Jul. 18, 2024
Jul. 15, 2024
May 30, 2024
Mar. 27, 2024
Oct. 06, 2023
Jun. 11, 2024
Dec. 31, 2024
Dec. 31, 2023
Stockholders’ Equity [Line Items]                  
Convertible preferred shares (in Shares)               45,000,000 45,000,000
Authorized shares (in Shares)               5,000,000  
Stockholders' Equity, Reverse Stock Split           1 for 15   1 for 15  
Stockholders' Equity Note, Stock Split               The effect of the reverse stock split was to combine every 15 shares of outstanding common stock into one share of common stock.  
Full settlement of accounts payable   $ 159,776 $ 38,052 $ 37,500     $ 239,815 $ 271,831 $ 188,804
Price of per share (in Dollars per share)   $ 1.36 $ 1.41 $ 2.34          
Common stock, shares issued (in Shares)               1,859,525 1,232,333
Settlement accounts payable $ 32,016                
Fair value per share (in Dollars per share) $ 1.16                
Shares of common stock valued   $ 218,094 $ 53,653 $ 87,600       $ 285,294
Gross proceeds               200,000  
Aggregate purchase     $ 4,887,118            
Issuance of warrants               973,200  
Black-Scholes Pricing Model [Member]                  
Stockholders’ Equity [Line Items]                  
Beneficial conversion               $ 6,163,572  
Warrant [Member]                  
Stockholders’ Equity [Line Items]                  
Exercise price of warrants (in Dollars per share)               $ 0.86  
Minimum [Member]                  
Stockholders’ Equity [Line Items]                  
Price of per share (in Dollars per share)             $ 1.2    
Exercise price of warrants (in Dollars per share)               1.25  
Exercise prices, decrease (in Dollars per share)     $ 1.43            
Maximum [Member]                  
Stockholders’ Equity [Line Items]                  
Price of per share (in Dollars per share)             $ 2.65    
Exercise price of warrants (in Dollars per share)               $ 1.375  
Exercise prices, increase (in Dollars per share)     $ 1.573            
Series A Convertible Preferred Stock [Member]                  
Stockholders’ Equity [Line Items]                  
Authorized shares (in Shares)               900,000 900,000
Authorized per share (in Dollars per share)               $ 0.001 $ 0.001
Common Stock [Member]                  
Stockholders’ Equity [Line Items]                  
Stock issued during period, restricted shares (in Shares)         1,667     1,667 16,935
Stock issued during period shares (in Shares)             130,039 157,639 69,072
Full settlement of accounts payable               $ 158 $ 69
Common stock, shares issued (in Shares) 27,600                
Shares issued for common stock placement (in Shares)               232,558  
Issuance of warrants